CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice

Gordon, 1989, High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies, Circulation, 79, 8, 10.1161/01.CIR.79.1.8 Badimon, 1989, High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits, Lab Invest, 60, 455 Badimon, 1990, Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit, J Clin Invest, 85, 1234, 10.1172/JCI114558 Ameli, 1994, Recombinant apolipoprotein a-i milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits, Circulation, 90, 1935, 10.1161/01.CIR.90.4.1935 Ibanez, 2008, Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein a-i milano (etc-216) administration: Magnetic resonance imaging study in an experimental model of atherosclerosis, J Am College Cardiol, 51, 1104, 10.1016/j.jacc.2007.09.071 Podrez, 2010, Anti-oxidant properties of high-density lipoprotein and atherosclerosis, Clin Exp Pharmacol physiol, 37, 719, 10.1111/j.1440-1681.2010.05380.x Tabet, 2009, High-density lipoproteins, inflammation and oxidative stress, Clin Sci (London, England: 1979), 116, 87, 10.1042/CS20080106 Navab, 2004, The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and hdl, J Lipid Res., 45, 993, 10.1194/jlr.R400001-JLR200 Duffy, 2006, Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport, Circulation, 113, 1140, 10.1161/CIRCULATIONAHA.105.593855 Julius, 2013, Nicotinic acid as a lipid-modifying drug - a review, Atheroscler Suppl, 14, 7, 10.1016/j.atherosclerosissup.2012.10.036 Barter, 2012, Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk, Journal of Lipid Res, 53, 1755, 10.1194/jlr.R024075 Duverger, 1996, Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein a-i-transgenic rabbits, Circulation, 94, 713, 10.1161/01.CIR.94.4.713 Soma, 1995, Recombinant apolipoprotein a-imilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits, Circul Res, 76, 405, 10.1161/01.RES.76.3.405 Nissen, 2003, Effect of recombinant apoa-i milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial, JAMA, 290, 2292, 10.1001/jama.290.17.2292 Tardif, 2007, Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial, JAMA, 297, 1675, 10.1001/jama.297.15.jpc70004 Barter, 2007, Effects of torcetrapib in patients at high risk for coronary events, N Engl J Med, 357, 2109, 10.1056/NEJMoa0706628 Group, 2010, Effects of combination lipid therapy in type 2 diabetes mellitus, N Engl J Med, 362, 1563, 10.1056/NEJMoa1001282 Nissen, 2007, Effect of torcetrapib on the progression of coronary atherosclerosis, The New Eng J Med, 356, 1304, 10.1056/NEJMoa070635 Mackey, 2012, High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: mesa (multi-ethnic study of atherosclerosis), J Am College of Cardiol, 60, 508, 10.1016/j.jacc.2012.03.060 van der Steeg Wa, 2008, High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein a-i: significance for cardiovascular risk: the ideal and epic-norfolk studies, J Am Coll Cardiol, 51, 634, 10.1016/j.jacc.2007.09.060 Wang, 2007, Macrophage abca1 and abcg1, but not sr-bi, promote macrophage reverse cholesterol transport in vivo, J Clin Invest, 117, 2216, 10.1172/JCI32057 Usui, 2002, A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by hplc, J Lipid Res., 43, 805, 10.1016/S0022-2275(20)30123-1 Bligh, 1959, A rapid method of total lipid extraction and purification, Can J Biochem Physiol, 37, 911, 10.1139/o59-099 Park, 2003, Involvement of transcription factors in plasma hdl protection against tnf-alpha-induced vascular cell adhesion molecule-1 expression, The Int J Biochem Cell Biol, 35, 168, 10.1016/S1357-2725(02)00173-5 Suc, 2003, Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse j774 macrophages: role of scavenger receptors, classes a and b, J Cell Sci, 116, 89, 10.1242/jcs.00126 Bortnick, 2000, The correlation of atp-binding cassette 1 mrna levels with cholesterol efflux from various cell lines, J Biol Chem, 275, 28634, 10.1074/jbc.M003407200 Cogny, 1996, High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells, Biochem J, 314, 285, 10.1042/bj3140285 Ross, 1999, Atherosclerosis - an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 Lewis, 2005, New insights into the regulation of hdl metabolism and reverse cholesterol transport, Circul Res, 96, 1221, 10.1161/01.RES.0000170946.56981.5c Kawano, 1993, Quantitation of pre beta-hdl-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid, Biochemistry, 32, 5025, 10.1021/bi00070a008 Sekiya, 2011, The role of neutral cholesterol ester hydrolysis in macrophage foam cells, J Atheroscler Thromb, 18, 359, 10.5551/jat.7013 Khera, 2011, Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis, N Eng J Med, 364, 127, 10.1056/NEJMoa1001689 Barter, 2004, Antiinflammatory properties of hdl, Circ Res., 95, 764, 10.1161/01.RES.0000146094.59640.13 Cockerill, 1995, High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules, Arterioscler Thromb Vasc Biol., 15, 1987, 10.1161/01.ATV.15.11.1987 Cockerill, 2001, High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock, FASEB J, 15, 1941, 10.1096/fj.01-0075com Ashby, 1998, Factors influencing the ability of hdl to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells, Arterioscler Thromb Vasc Biol., 18, 1450, 10.1161/01.ATV.18.9.1450 Cockerill, 2001, Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of e-selectin in an in vivo model of acute inflammation, Circulation, 103, 108, 10.1161/01.CIR.103.1.108 Feig, 2011, Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques, Circulation, 123, 989, 10.1161/CIRCULATIONAHA.110.984146 Tall, 2008, Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins, J Intern Med, 263, 256, 10.1111/j.1365-2796.2007.01898.x Glomset, 1973, The metabolic role of lecithin: cholesterol acyltransferase: perspectives from pathology, Adv Lipid Res., 11, 1, 10.1016/B978-0-12-024911-4.50008-8 Miettinen, 1989, Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels, Am J Clin Nutr, 49, 629, 10.1093/ajcn/49.4.629 Harchaoui, 2009, Reduced fecal sterol excretion in subjects with familial hypoalphalipoproteinemia, Atherosclerosis, 207, 614, 10.1016/j.atherosclerosis.2009.06.022 Eriksson, 1999, Stimulation of fecal steroid excretion after infusion of recombinant proapolipo protein a-i. Potential reverse cholesterol transport in humans, Circulation, 100, 594, 10.1161/01.CIR.100.6.594 Nanjee, 2001, Intravenous apoa-i/lecithin discs increase pre-beta-hdl concentration in tissue fluid and stimulate reverse cholesterol transport in humans, J Lipid Res., 42, 1586, 10.1016/S0022-2275(20)32212-4 Brousseau, 2005, Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein a-i metabolism, and fecal sterol excretion, Arterioscler Thromb Vasc Biol, 25, 1057, 10.1161/01.ATV.0000161928.16334.dd Brown, 1974, Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity, Proc Nat Acad Sci U S A, 71, 788, 10.1073/pnas.71.3.788 Hobbs, 1992, Molecular genetics of the ldl receptor gene in familial hypercholesterolemia, Hum Mutat, 1, 445, 10.1002/humu.1380010602